We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Adjustable Glasses Help the World's Poorest See Better

By HospiMedica International staff writers
Posted on 07 Jan 2009
An innovative pair of glasses which can be "tuned" by the wearer to correct his vision on his own could bring affordable spectacles to millions of people in the third world that would otherwise never be able to afford them.

An ambitious quest to offer glasses to a billion of the world's poorest people by 2020 has been launched by retired professor of physics Joshua Silver, Ph.D., of Oxford University (UK). More...
Some 30,000 pairs of the spectacles have already been distributed in 15 countries, but Professor Silver and his team plan to launch a trial in India, which will, they hope, distribute 1 million pairs of glasses. Their target is to distribute 100 million pairs annually, within a few years. With the global need for basic sight-correction, estimated at more than half the world's population, Professor Silver sees no reason to stop at a billion.

The Adaptive Eyecare (Oxford, UK) spectacles rely on the principle that the more curved a lens is, the more powerful it becomes--an optical function similar to that of the crystalline lens in the human eye. Inside the device's tough plastic outer lenses are two clear circular membrane sacs filled with fluid, each of which is connected to a small syringe attached to either arm of the spectacles. The wearer adjusts a dial on the syringe to add or reduce the amount of fluid in the membrane, thus changing the power of the lens. When the wearer is happy with the strength of each lens the membrane lens is sealed by twisting a small screw, and the ancillary syringes used for lens adjustment are removed. The process takes less than a minute for both eyes. The power range of the lens is +6 to -6 Dioptres, and the optical quality is similar to that of the typical human eye.

The implications of bringing glasses within the reach of poor communities are enormous, said Professor Silver. Literacy rates rise, fishermen are once again able to mend their nets, and women can return to weave cloth. During an early field trial in Ghana (funded by the British government), Professor Silver met a man called Henry Adjei-Mensah, whose sight had deteriorated with age, and who had been forced to retire as a tailor because he could no longer see to thread the needle of his sewing machine.

"So he retires. He was about 35. He could have worked for at least another 20 years,” recounted Professor Silver, who also founded Adaptive Eyecare. "We put these specs on him, and he smiled, and threaded his needle, and sped up with this sewing machine. He can work now. He can see.”

According to the World Health Organization (Geneva, Switzerland) there are currently around one billion people, including 10% of school children, in the world who would benefit from vision correction, but are as yet uncorrected, principally because the numbers of personnel trained to deliver vision correction in the conventional way are inadequate to meet the demand. Around one fifth of any group of people will need vision correction to get the best acuity their eyes can achieve; as a population get older, this fraction also rises, as a condition known as presbyopia--a diminution in the power of accommodation of the crystalline lens--develops. These statistics have profound implications, since hundreds of millions of adults do not have the vision correction they need to be socially and economically active, and many children are educationally and socially disadvantaged.

Related Links:

Oxford University
Adaptive Eyecare
World Health Organization


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mobile X-Ray System
K4W
LED Surgical Lamp
ACEMST35/57
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.